Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SATB1 antisense RNA 1 (SATB1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the SATB1 gene locus[4]. It is classified as an RNA gene, specifically within the lncRNA class, and is not a protein-coding gene nor a canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. There is no significant evidence that SATB1-AS1 acts as a direct therapeutic target, receptor, or biomarker in current clinical or translational research. Its biological function, involvement in diseases, interacting drugs, or mechanisms of action remain undetermined in the referenced databases[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SATB1 antisense RNA 1 (SATB1-AS1).